Bhisetti; Govinda Rao

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bhisetti; Govinda Rao.The latest application filed is for "benzimidazole analogues for the treatment or prevention of flavivirus infections".

Company Profile

2.16.14

Bhisetti; Govinda Rao - Lexington MA
- Lexington MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzimidazole Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20140243257 - Henderson; James A. ; et al.	2014-08-28
Benzimidazole analogues for the treatment or prevention of flavivirus infections Grant 8,765,731 - Henderson , et al. July 1, 2	2014-07-01
Co-crystals and pharmaceutical compositions comprising the same Grant 8,759,353 - Connelly , et al. June 24, 2	2014-06-24
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases Grant 08618152 -	2013-12-31
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases Grant 8,618,152 - Farmer , et al. December 31, 2	2013-12-31
Benzimidazole Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20130157997 - Henderson; James A. ; et al.	2013-06-20
Benzimidazole analogues for the treatment or prevention of flavivirus infections Grant 8,354,419 - Henderson , et al. January 15, 2	2013-01-15
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Proteases App 20120014914 - Farmer; Luc J. ; et al.	2012-01-19
Benzimidazole Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20110172238 - Henderson; James A. ; et al.	2011-07-14
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease App 20110112114 - Tung; Roger D. ; et al.	2011-05-12
Inhibitors of tace Grant 7,919,520 - Bandarage , et al. April 5, 2	2011-04-05
Co-Crystals and Pharmaceutical Compositions Comprising the Same App 20110059987 - Connelly; Patrick R. ; et al.	2011-03-10
Inhibitors Of Tace App 20090176782 - Bandarage; Upul ; et al.	2009-07-09
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Grant 7,494,988 - Perni , et al. February 24, 2	2009-02-24
Inhibitors of TACE Grant 7,485,664 - Bandarage , et al. February 3, 2	2009-02-03
Inhibitors Of Serine Protease, Particularly Hcv Ns3-ns4a Protease App 20090022688 - Farmer; Luc J. ; et al.	2009-01-22
Novel sulfonamide inhibitors of aspartyl protease App 20080293727 - Tung; Roger D. ; et al.	2008-11-27
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20050090450 - Farmer, Luc J. ; et al.	2005-04-28
Inhibitors of TACE App 20040186088 - Bandarage, Upul ; et al.	2004-09-23
Novel sulfonamide inhibitors of aspartyl protease App 20040167116 - Tung, Roger D. ; et al.	2004-08-26
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease App 20040077600 - Tung, Roger D. ; et al.	2004-04-22
Sulfonamide inhibitors of aspartyl protease Grant 6,720,335 - Tung , et al. April 13, 2	2004-04-13
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease App 20030236242 - Perni, Robert ; et al.	2003-12-25
Inhibitors of serine proteases, particularly HCV NS3 protease Grant 6,608,067 - Tung , et al. August 19, 2	2003-08-19
Sulfonamide inhibitors of aspartyl protease Grant 5,977,137 - Tung , et al. November 2, 1	1999-11-02
Aspartyl protease inhibitors Grant 5,945,413 - Tung , et al. August 31, 1	1999-08-31
Aspartyl protease inhibitors Grant 5,883,252 - Tung , et al. March 16, 1	1999-03-16
Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease Grant 5,691,372 - Tung , et al. November 25, 1	1997-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.